Ro.co vs bmiMD: Oral Wegovy pill vs compounded tirzepatide
Quick verdict: Ro.co is the choice for patients who prioritize access to the FDA-approved Wegovy pill and a low $39 online get-started fee, while bmiMD is aimed at people seeking lower long-term monthly pricing on compounded tirzepatide with multi-month plans and free shipping. This comparison highlights the most distinctive differences between Ro.co and bmiMD.
Start Ro.co: Get Started Online for Just $39
How they differ at a glance
Compare Ro.co vs bmiMD on medication type, starting cost and billing options, regulatory status of medications, and shipping and access features. Below are the core differences drawn only from the supplied source facts.
| Criteria | Ro.co | bmiMD |
|---|---|---|
| Medication type | Wegovy pill, FDA-approved oral GLP-1 | Compounded tirzepatide (GLP-1/GIP) |
| Starting price | Get started online for just $39 | Starting at $139/month (12-month plan); other plan tiers available |
| Billing options | Direct-pay entry point; ongoing pricing varies by plan and medication | Four billing options: 1, 3, 6, or 12 month plans with lower monthly rates for longer commitments |
| Shipping and delivery | Shipping details not verified on captured page | Free subscription shipping on every order |
| Clinician review and access | Treatment available only when a licensed clinician determines it is medically appropriate; pricing disclosed before consultation | Treatment available only when a licensed clinician determines it is medically appropriate; 24/7 clinician access noted |
| Regulatory note | Offers FDA-approved finished medication; compounded medications are not FDA-approved | Compounded medication is not FDA-approved and is not reviewed by FDA for safety, effectiveness or quality |
Medication type and regulatory status
Ro.co provides access to the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication on this list. The source emphasizes that this is a finished, FDA-approved product. By contrast, bmiMD offers compounded tirzepatide, and the captured evidence states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. That regulatory distinction is a primary differentiator for patients weighing oral branded medication versus compounded alternatives.
Explore bmiMD: Compounded tirzepatide plans from $139/month
Price structure and billing commitments
Ro.co promotes a low entry cost: you can get started online for just $39, with ongoing branded medication pricing disclosed before completing a consultation. The source notes branded medications can cost significantly more than compounded alternatives. bmiMD lists multiple billing options with month-to-month pricing that falls as low as $139/month for a 12-month plan, $149/month for six months, $159/month for three months, and $179/month for a one-month option. bmiMD’s lowest monthly equivalent requires a longer commitment, which is important to confirm before enrollment.
Begin Ro.co consults: See pricing before you finish
Access, shipping and service features
bmiMD highlights free subscription shipping on every order, online refills and delivery, and 24/7 clinician access. Ro.co’s captured page emphasizes no hidden fees and that pricing is disclosed before completing a consultation, and notes Ro is an established full-service telehealth platform. The Ro.co capture did not verify shipping or membership specifics on the captured page, while bmiMD explicitly advertises free shipping and online refill delivery.
Who each provider is best for
Based on the supplied facts: Ro.co is best for patients who prioritize access to the FDA-approved Wegovy pill, prefer an oral option and value transparent upfront pricing with a $39 get-started fee. bmiMD is best for people who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment and who want lower long-term monthly equivalents through multi-month plans with free shipping and 24/7 clinician access.
View bmiMD plans and billing options
Final comparison and quick recap
Ro.co vs bmiMD centers on oral FDA-approved Wegovy pill access and a $39 start fee at Ro.co versus bmiMD’s compounded tirzepatide with tiered monthly pricing as low as $139/month with free shipping and multi-month commitments. Compounded medications from bmiMD are explicitly noted as not FDA-approved in the captured evidence. Treatment at both providers is available only when a licensed clinician determines it is medically appropriate.
Choose Ro.co if you want the FDA-approved Wegovy pill, an injection-free oral GLP-1 option, transparent pricing up front and a $39 get-started entry point. Choose bmiMD if you want compounded tirzepatide with multiple billing options, free subscription shipping, and lower long-term monthly pricing with a required commitment to secure the lowest rate.